Insulet (PODD) Reports In-Line Q2 EPS, FY Revenue Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Insulet Corporation (PODD) PT Raised to $58 at Jefferies
August 4, 2017 8:38 AM EDTJefferies raised its price target on Insulet Corporation (NASDAQ: PODD) to $58.00 (from $48.00) while maintaining a Buy rating following the company's 2Q conference call.
The company provided more detail on the plans it announced on July 20 to abandon its distributor Ypsomed and go... More
Insulet Corporation (PODD) PT Raised to $63 at Cowen on 2Q Report; 'Direct Europe Commercialization Drives Sharp Upward Estimate Revisions'
August 4, 2017 6:42 AM EDTCowen raised its price target on Insulet Corporation (NASDAQ: PODD) to $63.00 (from $52.00) while maintaining a Outperform rating, following the company's second quarter earnings report.
Analyst Doug Schenkel notes the company delivered second quarter revenues above consensus projections, despite offering earnings per share results below... More



